Prescriber Scope of Practice for Anxiety in California

If you’re a psychiatrist treating anxiety via telehealth, you already know the clinical side cold — but navigating the regulatory maze? That’s where things get messy. Federal DEA rules, state-by-state prescribing laws, PDMP requirements, and constantly shifting telehealth regulations can make you feel like you need a law degree just to write a benzodiazepine prescription.

Here’s the reality: telehealth prescribing laws for psychiatrists are a patchwork of federal and state rules that directly impact how you treat anxiety disorders. Get it wrong, and you’re looking at compliance violations, board discipline, or worse. Get it right, and you’ve got a scalable, compliant practice that lets you help more patients without the overhead of traditional office-based care.

This guide breaks down exactly what psychiatrists need to know about telehealth prescribing laws — from DEA extensions through 2025 to state-specific rules on controlled substances, PDMP checks, and NP scope limitations. Whether you’re already practicing via telehealth or considering joining a platform like Klarity Health, understanding these regulations isn’t optional.

The Federal Baseline: DEA Rules on Prescribing Controlled Substances via Telehealth

Let’s start with the big one: can you prescribe benzodiazepines and other controlled medications via telehealth in 2025? The short answer is yes — but it’s temporary.

Under normal circumstances, the Ryan Haight Act (21 U.S.C. §829(e)) requires an in-person medical evaluation before prescribing any controlled substance ‘by means of the Internet.’ That meant pre-COVID, if you wanted to start a patient on Xanax for panic disorder, you legally needed to see them face-to-face at least once.

COVID changed everything. In March 2020, the DEA invoked public health emergency exceptions that allowed controlled substance prescribing via telehealth without prior in-person exams. This was initially temporary — but the DEA has extended these flexibilities three times. Most recently, in November 2024, the DEA announced these waivers will remain in effect through December 31, 2025.

What This Means for Your Practice Right Now

As of February 2026, you can:

• Conduct a telehealth evaluation of a new anxiety patient (via live video)
• Diagnose an anxiety disorder
• Prescribe Schedule II–V controlled substances (including benzodiazepines like alprazolam, lorazepam, clonazepam)
• E-prescribe to the patient’s pharmacy
• Continue treatment entirely via telehealth

The catch? This flexibility might not last. The DEA proposed new rules in 2023 that would have reinstated in-person visit requirements — drawing over 38,000 public comments from mental health providers who argued it would devastate access to care. The DEA postponed those rules and is currently seeking a ‘new path forward for telemedicine,’ but there’s no guarantee future regulations won’t require hybrid care models (like allowing initial prescriptions via telehealth but mandating in-person follow-ups).

What You Must Do to Stay Compliant

Even under temporary waivers, you’re still bound by standard controlled substance regulations:

• DEA Registration: You must have a current DEA number in your state of practice
• Documentation: Chart every telehealth encounter as thoroughly as you would in-person
• Standard of Care: The exam must be clinically appropriate — a 5-minute video chat won’t cut it
• State PDMP Checks: Most states require checking prescription monitoring databases (see state-specific sections below)
• E-Prescribing: Nearly all states mandate electronic prescribing for controlled substances

Bottom line: Federal law currently allows you to prescribe anxiolytics via telehealth, but this is a moving target. Stay plugged into DEA updates and be prepared to adjust your practice model if regulations change in 2026 or beyond.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists’ Scope of Practice: Full Authority, Full Responsibility

Here’s the good news: as a psychiatrist (MD or DO), your scope of practice for treating anxiety is unrestricted. You can:

• Diagnose any anxiety disorder (GAD, panic disorder, social anxiety, OCD, PTSD, etc.)
• Prescribe any medication — from SSRIs and SNRIs to benzodiazepines and even Schedule II substances if clinically indicated
• Provide psychotherapy (though most psychiatrists focus on medication management due to time constraints)
• Practice independently in every state — no supervision or collaborative agreements required

This independence is your competitive advantage over NPs and PAs, who face varying scope restrictions depending on the state (more on that below). But with that authority comes responsibility: you’re individually accountable for prescribing decisions, monitoring for dependence (especially with benzos), and adhering to best practices.

Multi-State Licensure: The Real Barrier

The regulatory challenge for psychiatrists isn’t scope limitations — it’s geography. You must hold a valid medical license in every state where your patients are located. Treating a California patient via telehealth from your New York office? You need both a NY and CA license.

Interstate Medical Licensure Compact (IMLC) can streamline this process. Member states include Texas, Illinois, Pennsylvania, and Florida — but notably not California or New York. If you want to practice in those high-population states, you’re going through the conventional licensing process, which can take 3-6 months and cost $1,000+ per state.

Platforms like Klarity Health often assist providers with multi-state licensing because it’s critical to scaling telehealth operations. You can’t serve a national patient base without the licenses to back it up.

PMHNPs and Anxiety Treatment: State-by-State Scope Variations

Psychiatric Mental Health Nurse Practitioners are essential to meeting the demand for mental health care — but their ability to treat anxiety independently varies dramatically by state.

Practice Authority: Full, Reduced, or Restricted

States fall into three categories for NP practice:

Full Practice Authority (FPA): NPs can evaluate, diagnose, and prescribe independently without physician oversight. Examples:

• Illinois (after 4,000 hours of experience)
• New York (after 3,600 hours under physician collaboration)
• California (transitioning to full independence by 2026 under AB 890)

Reduced/Restricted Practice: NPs must have a formal collaboration or supervision agreement with a physician:

• Texas (Prescriptive Authority Agreement required)
• Florida (supervisory protocol with a physician)
• Pennsylvania (collaborative agreement with physician)

Controlled Substance Prescribing Limits for NPs

Most anxiety medications (SSRIs, buspirone) aren’t controlled and pose no regulatory issues for NPs. The complications arise with benzodiazepines (Schedule IV) and stimulants (Schedule II, for comorbid ADHD).

Texas: The Most Restrictive

Texas APRNs cannot prescribe Schedule II controlled substances outside of hospital or hospice settings. Period. A Texas PMHNP treating anxiety via telehealth cannot prescribe Adderall for comorbid ADHD — that must come from a physician.

Schedule III–V (including benzos) can be prescribed under the Prescriptive Authority Agreement, but the NP remains under physician oversight.

Florida: Psychiatric Carve-Out

Florida limits NPs to 7-day supplies of Schedule II drugs — unless the NP is a certified psychiatric nurse treating mental illness. This carve-out allows PMHNPs to prescribe psychiatric Schedule IIs (like stimulants for ADHD) without the 7-day restriction. For anxiety, most meds are Schedule IV (benzos), which aren’t subject to this limit.

Pennsylvania: Quantity Caps

PA allows NPs to prescribe Schedule II drugs for up to 30 days and Schedule III–IV for up to 90 days, but always under physician collaboration. The collaborating physician must be notified of Schedule II prescriptions within 24 hours.

Illinois: FPA with Opioid Consultation

NPs with Full Practice Authority in Illinois can prescribe Schedule II–V independently. The one exception: if prescribing Schedule II opioids (not relevant to most anxiety care), they must have a physician consultation relationship for the first 5 years of FPA.

For benzodiazepines (Schedule IV), fully independent NPs in Illinois have no restrictions beyond standard controlled substance laws.

Why This Matters for Telehealth Platforms

If you’re joining a platform like Klarity Health, the infrastructure must accommodate these state-specific rules. In restrictive states (TX, FL, PA), the platform needs physician collaborators available. In full-practice states (NY, IL), experienced NPs can operate autonomously.

For patients, this is mostly invisible — but for providers, it’s critical compliance infrastructure. A Texas PMHNP treating anxiety via Klarity can prescribe Lexapro and Ativan all day long, but if a patient needs Vyvanse for ADHD, a psychiatrist has to step in.

State-Specific Telehealth Prescribing Rules: What You Need to Know

Federal DEA rules set the floor, but states add layers of requirements that vary wildly. Here are the critical points for the six highest-volume states for telehealth psychiatry:

California: Telehealth-Friendly, License-Unfriendly

No in-person exam required. California explicitly allows prescribing medications (including controlled substances) based on a telehealth exam that meets the standard of care — even asynchronous methods like questionnaires can be part of the evaluation if clinically appropriate.

PDMP checks: California’s CURES database must be checked before prescribing Schedule II–IV drugs and at least every 4 months for ongoing therapy.

E-prescribing: Mandatory for all prescriptions since 2022.

The catch: California doesn’t participate in IMLC, so out-of-state psychiatrists must go through the full CA licensing process. No shortcuts.

Texas: Audio-Visual Requirement, Pain Management Restrictions

Telehealth is permitted if you establish a valid patient relationship via real-time audio-video. Phone-only won’t cut it for new patients in Texas.

Controlled substances via telehealth are allowed for psychiatric conditions — but there’s a major carve-out: prescribing Schedule II drugs for chronic pain via telemedicine is prohibited (except in extremely limited cases). This doesn’t affect most anxiety treatment, but it’s a reminder that Texas regulates telehealth closely.

PDMP checks: Texas mandates checking the state PMP before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.

IMLC member: Out-of-state physicians can use the compact to obtain a Texas license more easily.

Florida: Psychiatric Exception to Schedule II Ban

Florida prohibits Schedule II prescribing via telehealth — except for psychiatric treatment, inpatient care, hospice, or nursing homes. This means you can prescribe Adderall or other Schedule IIs via telehealth for psychiatric conditions (like ADHD or treatment-resistant anxiety), but the same drug for weight loss or pain would be prohibited.

PDMP checks: Required before prescribing any Schedule II–V controlled substance and every 90 days for ongoing therapy (E-FORCSE database).

Informed consent: Florida requires written patient consent for telehealth treatment.

Out-of-state telehealth registration: Florida offers a special registration for out-of-state providers to practice telehealth without obtaining a full FL license — a rare and valuable option.

New York: I-STOP and Mandatory E-Prescribing

No in-person exam required by state law. Telehealth exams are acceptable as long as they meet the standard of care.

I-STOP PDMP checks: New York requires prescribers to check the state’s Prescription Monitoring Program before every Schedule II, III, or IV prescription — including benzodiazepines. This is one of the strictest PDMP laws in the country.

E-prescribing: Mandatory for all prescriptions (since 2016).

NP independence: Experienced NPs (3,600+ hours) can practice independently without physician collaboration as of 2022.

Pennsylvania: PDMP Checks for Every Benzo Prescription

No statewide telehealth statute until recently, but boards permit telemedicine if standard of care is met. Real-time audio-video is recommended for initial evaluations.

PDMP checks: Pennsylvania requires checking the state PDMP before every prescription of benzodiazepines or opioids — not just the first one. This is more frequent than most states and adds an administrative step to every refill.

E-prescribing: Mandatory for controlled substances (with limited exceptions) since 2019.

IMLC member: Out-of-state physicians can use the compact for PA licensure.

Illinois: Full NP Independence, Audio-Only Allowed

Telehealth broadly permitted. Illinois doesn’t require in-person exams and explicitly allows audio-only telehealth for mental health services if the patient lacks video access.

PDMP checks: Required for all Schedule II prescriptions; strongly encouraged for benzodiazepines.

State controlled substance license: All prescribers (MDs and NPs) must have a separate Illinois controlled substance license in addition to their DEA registration.

IMLC member: Physicians can obtain IL licenses through the compact.

The Economics of Telehealth Prescribing: Why Platforms Make Sense

Let’s talk about the elephant in the room: patient acquisition costs.

If you’re building a solo telehealth practice, you face:

• SEO: 6-12 months of investment before generating meaningful traffic, $2,000-5,000/month for content and technical optimization
• Google Ads: $15-40+ per click for mental health keywords, with most clicks not converting to booked patients. Realistic cost per booked patient: $200-400+
• Directory listings: Psychology Today, Zocdoc, and others charge monthly fees ($35-100+ per month) and you’re competing with hundreds of other providers
• Failed campaigns: Most solo providers waste months testing channels that don’t work

Total cost to acquire a qualified psychiatric patient through DIY marketing: $200-500+ when you factor in all costs — ad spend, agency fees, staff time, no-show rates, and months of trial and error.

The Klarity Health Model: Pay Only for Patients You See

Klarity uses a pay-per-appointment model similar to Zocdoc, but with a critical difference: you only pay when a pre-qualified patient books and shows up for an appointment.

• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Instead of gambling $3,000-5,000/month on marketing channels with uncertain ROI, you pay a standard listing fee per new patient lead. That’s guaranteed ROI — no patient, no payment.

For psychiatrists scaling a practice or NPs in states with collaborative agreement requirements, platforms like Klarity also handle:

• Multi-state licensing support
• Physician collaborator networks (for restrictive states)
• PDMP integration
• E-prescribing infrastructure
• Compliance monitoring for state-specific rules

The alternative? Hiring a marketing agency, building your own tech stack, managing multi-state compliance solo, and hoping enough patients show up to justify the overhead.

What’s Coming: Preparing for Post-2025 DEA Rules

The DEA’s current extension runs through December 31, 2025 — but don’t assume that’s the end of the story.

The agency is developing new telemedicine regulations that could:

• Reinstate in-person visit requirements for controlled substance prescribing
• Allow limited telehealth prescriptions (e.g., 30-day supplies) before mandating in-person follow-up
• Create a formal ‘Special Telemedicine Registration’ for providers (mentioned in the Ryan Haight Act but never implemented)

How to Prepare

1. Build hybrid care capabilities now. Consider partnerships with brick-and-mortar clinics or urgent care centers where patients can receive in-person evaluations if needed.

2. Diversify your treatment protocols. Not every anxiety patient requires benzodiazepines. SSRIs, SNRIs, buspirone, hydroxyzine, and beta-blockers are all non-controlled options that won’t be affected by DEA rule changes.

3. Stay plugged into regulatory updates. The DEA will likely propose new rules in 2025 with a public comment period. Industry groups (APA, AANP) will mobilize responses — participate and make your voice heard.

4. Document everything. If new rules require proving that telehealth encounters met clinical standards, thorough documentation will be your best defense.

FAQ: Telehealth Prescribing for Psychiatrists

Can I prescribe benzodiazepines via telehealth in 2025?
Yes, under current DEA waivers (extended through December 31, 2025). You must conduct an appropriate telehealth evaluation and comply with state PDMP and e-prescribing requirements.

Do I need an in-person visit before prescribing controlled substances?
Not currently, due to federal COVID-era waivers. However, this could change in 2026 if the DEA implements new regulations.

Can I treat patients in other states via telehealth?
Only if you hold an active medical license in the state where the patient is located. IMLC membership can streamline multi-state licensing for physicians.

What’s the difference between a psychiatrist and PMHNP for telehealth prescribing?
Psychiatrists have full independent practice authority in all states. PMHNPs face varying restrictions: some states require physician collaboration, and many limit NP prescribing of Schedule II controlled substances.

Do I have to check the PDMP every time I prescribe a benzodiazepine?
It depends on the state. Pennsylvania requires PDMP checks for every benzodiazepine prescription. New York requires checks for every Schedule II–IV prescription. Other states mandate checks at initial prescription and periodic intervals (e.g., every 30-90 days).

Can I use audio-only telehealth for anxiety treatment?
Some states (like Illinois) explicitly permit audio-only telehealth for mental health services. However, federal DEA rules strongly favor video for controlled substance prescribing. Best practice: use video for all new patient evaluations.

What happens if I prescribe to a patient in a state where I’m not licensed?
That’s practicing medicine without a license — a serious legal violation that can result in board discipline, criminal charges, and loss of licensure.

How do telehealth platforms handle multi-state compliance?
Reputable platforms like Klarity Health handle state-specific requirements by ensuring providers have appropriate licenses, arranging physician collaborators in restricted states, integrating PDMP checks, and maintaining e-prescribing infrastructure.

The Bottom Line: Compliance Isn’t Optional, But It Doesn’t Have to Be Overwhelming

Telehealth prescribing laws for psychiatrists are complex — but they’re navigable if you understand the framework: federal DEA rules set the baseline, state laws add specific requirements, and your license type (MD vs NP) determines your scope and independence.

What you need to succeed:

• Valid medical licenses in every state where you practice
• DEA registration and state controlled substance permits
• PDMP access and e-prescribing capability
• Documentation systems that meet standard-of-care requirements
• A clear understanding of state-specific rules for your license type

Or you can join a platform that handles this infrastructure for you. Klarity Health equips psychiatrists and PMHNPs with the licensing support, compliance infrastructure, and pre-qualified patient flow to build a telehealth practice without the overhead of solo DIY marketing.

The demand for anxiety treatment isn’t going away — but the window for telehealth prescribing flexibility under current federal rules might close. If you’ve been considering telehealth, now is the time to build compliant systems and patient flow before regulations potentially tighten in 2026.

Ready to explore telehealth psychiatry without the marketing gamble? Klarity Health connects providers with patients who are already seeking anxiety treatment, handling the patient acquisition, compliance, and tech stack so you can focus on what you do best: clinical care.

References

1. DEA & HHS (November 15, 2024). ‘DEA and HHS Extend Telemedicine Flexibilities through 2025.’ U.S. Drug Enforcement Administration Press Release. https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. Cornell Law School Legal Information Institute (Current through 2025). ’21 U.S.C. § 829(e) – Prescriptions via Internet (Ryan Haight Act).’ https://www.law.cornell.edu/uscode/text/21/829

3. Center for Connected Health Policy (Updated January 9, 2026). ‘State Telehealth Policies: Online Prescribing.’ https://www.cchpca.org/topic/online-prescribing/

4. Florida Statutes (2025 Edition). ‘456.47 – Telehealth Services’ and ‘464.012 – Advanced Practice Registered Nurses.’ http://www.leg.state.fl.us/Statutes/

5. New York State Department of Health (Effective August 27, 2013; accessed 2025). ‘I-STOP/Prescription Monitoring Program Requirements.’ https://health.ny.gov/professionals/narcotic/prescription_monitoring

Source:

• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=forward%20for%20telemedicine%2C%20DEA%20and,through%20the%20end%20of%202024
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Controlled%20Substance%20Act
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Note%20that%20the%20practice%20of,chapter%205%20of%20title%205
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,services%20within%20the%20applicable%20scope
• https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/#:~:text=Effective%20August%2027%2C%202013%2C%20most,to%20view%20dispensed%20controlled%20substance
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=may%20prescribe%20Schedule%20II%20drugs%3F,care%20from%20a%20qualified%20hospice
• https://www.leg.state.fl.us/Statutes/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=893.03%20to%20a%207,formulary%20which%20it%20finds%20is
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Additionally%2C%20the%20rule%20shall%20state,addiction%20medicine%2C%20or%20palliative%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=The%20Attorney%20General%20may%20issue,application%20for%20such%20special%20registration%E2%80%94